This site is intended only for healthcare professionals resident in the Republic of Ireland
|Adverse reaction||Patients, %|
|Infections and infestations|
|Blood and lymphatic system disorder|
|Metabolism and nutrition disorders|
|Nervous system disorders|
|General disorders and administration site conditions|
|Injury, poisoning and procedural complications|
|Infusion related reactions||10|
Please click here to view the importance of transplant and VOD mitigation with BESPONSA in patients with R/R B-Cell ALL
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023